GRCE insider filings

Grace Therapeutics, Inc. — 34 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-18. Screen GRCE transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 20 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Opaleye Management Inc. — 10% owner1125 legs · 358,002 sh · $684,410——
Kohli Prashant — Chief Executive Officer, Director21 leg · 100,000 sh · $214,000—1
DAVIS A BRIAN — Director1——1
DelAversano Robert J — Principal Financial Officer1——1
Kavuru Vimal — Director1——1
Kottayil George — Director1——1
Kumar Amresh — VP Program Management1——1
Macdonald R. Loch — Chief Medical Officer1——1
NEUGEBOREN EDWARD — Director1——1

Recent insider filings — Grace Therapeutics, Inc.

FiledFormInsiderReported transactionsSource
2026-11-184Opaleye Management Inc. — 10% ownerPurchase (P): 15,879 @ $1.76 · Purchase (P): 29,207 @ $1.72 · Purchase (P): 2,974 @ $1.73EDGAR
2026-11-054Opaleye Management Inc. — 10% ownerPurchase (P): 10,328 @ $1.79 · Purchase (P): 5,027 @ $1.80 · Purchase (P): 3,087 @ $1.77EDGAR
2026-10-264Opaleye Management Inc. — 10% ownerPurchase (P): 21,390 @ $1.93 · Purchase (P): 66,411 @ $1.77EDGAR
2026-10-214Opaleye Management Inc. — 10% ownerPurchase (P): 4,256 @ $1.88EDGAR
2026-10-164Opaleye Management Inc. — 10% ownerPurchase (P): 11,233 @ $1.93 · Purchase (P): 23,485 @ $1.95 · Purchase (P): 36,347 @ $1.89EDGAR
2026-10-134Opaleye Management Inc. — 10% ownerPurchase (P): 2,077 @ $2.02 · Purchase (P): 5,340 @ $2.04 · Purchase (P): 7,215 @ $2.02EDGAR
2026-10-054Opaleye Management Inc. — 10% ownerPurchase (P): 38,796 @ $2.04 · Purchase (P): 20,000 @ $2.07 · Purchase (P): 1,694 @ $2.06EDGAR
2026-10-014Opaleye Management Inc. — 10% ownerPurchase (P): 7,849 @ $2.09EDGAR
2026-10-014/AOpaleye Management Inc. — 10% ownerPurchase (P): 9,771 @ $2.10 · Purchase (P): 5,318 @ $2.10EDGAR
2026-09-234Opaleye Management Inc. — 10% ownerPurchase (P): 9,771 @ $2.10 · Purchase (P): 5,318 @ $2.10EDGAR
2026-09-214Kavuru Vimal — DirectorGrant/award (A): 12,200 (derivative) @ $0EDGAR
2026-09-214DAVIS A BRIAN — DirectorGrant/award (A) @ $0EDGAR
2026-09-214NEUGEBOREN EDWARD — DirectorGrant/award (A): 12,200 (derivative) @ $0EDGAR
2026-09-214Kottayil George — DirectorGrant/award (A): 12,200 (derivative) @ $0EDGAR
2026-09-104Opaleye Management Inc. — 10% ownerPurchase (P): 9,393 @ $2.10 · Purchase (P): 5,836 @ $2.09EDGAR
2026-09-104Kohli Prashant — Chief Executive Officer, DirectorPurchase (P): 100,000 @ $2.14EDGAR
2026-09-014DelAversano Robert J — Principal Financial OfficerGrant/award (A): 33,660 (derivative) @ $0EDGAR
2026-09-014Macdonald R. Loch — Chief Medical OfficerGrant/award (A): 54,690 (derivative) @ $0EDGAR
2026-09-014Kohli Prashant — Chief Executive Officer, DirectorGrant/award (A): 267,160 (derivative) @ $0EDGAR
2026-09-014Kumar Amresh — VP Program ManagementGrant/award (A): 35,760 (derivative) @ $0EDGAR
2026-08-194Opaleye Management Inc. — 10% ownerPurchase (P): 11,608 @ $2.09EDGAR
2026-01-124Kavuru Vimal — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2026-01-124Kottayil George — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2026-01-124NEUGEBOREN EDWARD — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2026-01-124DAVIS A BRIAN — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2025-05-134Kottayil George — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2025-05-134Kavuru Vimal — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2025-05-134NEUGEBOREN EDWARD — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2025-05-134DAVIS A BRIAN — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2025-04-164Kumar Amresh — VP Program ManagementGrant/award (A): 30,000 (derivative) @ $0EDGAR
2025-04-164Macdonald R. Loch — Chief Medical OfficerGrant/award (A): 40,000 (derivative) @ $0EDGAR
2025-04-164DelAversano Robert J — Principal Financial OfficerGrant/award (A): 20,130 (derivative) @ $0EDGAR
2025-04-164Kohli Prashant — Chief Executive Officer, DirectorGrant/award (A): 225,400 (derivative) @ $0EDGAR
2025-04-164D'Andrea Carrie — VP Clinical OperationsGrant/award (A): 30,000 (derivative) @ $0EDGAR

Recent 8-K events — Grace Therapeutics, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-188-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-08-138-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-068-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-288-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-188-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-188-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-058-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-278-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-238-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=GRCE returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs